SE7500130L - - Google Patents

Info

Publication number
SE7500130L
SE7500130L SE7500130A SE7500130A SE7500130L SE 7500130 L SE7500130 L SE 7500130L SE 7500130 A SE7500130 A SE 7500130A SE 7500130 A SE7500130 A SE 7500130A SE 7500130 L SE7500130 L SE 7500130L
Authority
SE
Sweden
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
SE7500130A
Other languages
English (en)
Other versions
SE427238B (sv
Inventor
H Bachmayer
G Schmidth
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7500130L publication Critical patent/SE7500130L/
Publication of SE427238B publication Critical patent/SE427238B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500130A 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter SE427238B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 ( ) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
SE7500130L true SE7500130L ( ) 1975-07-15
SE427238B SE427238B (sv) 1983-03-21

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500130A SE427238B (sv) 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter

Country Status (27)

Country Link
JP (2) JPS58407B2 ( )
AT (1) AT345449B ( )
AU (1) AU500250B2 ( )
BE (1) BE824372A ( )
CA (1) CA1049406A ( )
CH (1) CH589453A5 ( )
CS (1) CS191254B2 ( )
DD (1) DD116239A5 ( )
DE (1) DE2500785B2 ( )
DK (1) DK140003B ( )
ES (1) ES433759A1 ( )
FI (1) FI54053C ( )
FR (1) FR2257305B1 ( )
GB (1) GB1498261A ( )
HK (1) HK56380A ( )
HU (1) HU173920B ( )
IE (1) IE40794B1 ( )
IL (1) IL46426A ( )
MY (1) MY8100204A ( )
NL (1) NL166622C ( )
NO (1) NO143128C ( )
PH (1) PH14458A ( )
PL (1) PL93689B1 ( )
SE (1) SE427238B ( )
SU (1) SU616997A3 ( )
YU (1) YU41289B ( )
ZA (1) ZA75259B ( )

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ES2525518T3 (es) * 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
CA2696090C (en) * 2007-08-28 2017-06-13 Baxter International Inc. Method for producing viral vaccines
KR20160068972A (ko) 2013-11-15 2016-06-15 노파르티스 아게 잔여 세포 배양 불순물의 제거

Also Published As

Publication number Publication date
DE2500785C3 ( ) 1980-09-11
HK56380A (en) 1980-10-16
IE40794L (en) 1975-07-14
PH14458A (en) 1981-07-29
FI54053C (fi) 1978-10-10
FR2257305A1 ( ) 1975-08-08
YU5875A (en) 1984-04-30
DE2500785A1 (de) 1975-07-31
MY8100204A (en) 1981-12-31
GB1498261A (en) 1978-01-18
JPS58407B2 (ja) 1983-01-06
SU616997A3 (ru) 1978-07-25
SE427238B (sv) 1983-03-21
AU500250B2 (en) 1979-05-17
PL93689B1 ( ) 1977-06-30
IL46426A (en) 1978-01-31
NO750031L ( ) 1975-08-11
FI54053B (fi) 1978-06-30
IE40794B1 (en) 1979-08-15
NL166622B (nl) 1981-04-15
ATA21475A (de) 1978-01-15
FR2257305B1 ( ) 1982-03-19
FI750014A ( ) 1975-07-15
CH589453A5 ( ) 1977-07-15
JPS50100224A ( ) 1975-08-08
JPS6035326B2 (ja) 1985-08-14
ES433759A1 (es) 1977-02-16
NO143128B (no) 1980-09-15
NL7500301A (nl) 1975-07-16
HU173920B (hu) 1979-09-28
DD116239A5 ( ) 1975-11-12
YU41289B (en) 1987-02-28
IL46426A0 (en) 1975-04-25
NL166622C (nl) 1981-09-15
CS191254B2 (en) 1979-06-29
BE824372A (fr) 1975-07-14
DK140003C ( ) 1979-10-29
JPS56127319A (en) 1981-10-06
DK140003B (da) 1979-06-05
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
CA1049406A (en) 1979-02-27
AT345449B (de) 1978-09-11
DE2500785B2 (de) 1980-01-03
DK1475A ( ) 1975-09-01
AU7730575A (en) 1976-07-15

Similar Documents

Publication Publication Date Title
Carter Jr Role of sulfhydryl groups in erythrocyte membrane structure
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
SE7500130L ( )
KR850001700A (ko) 단순 헤르페스 바이러스 서브유니트 왁진(Herpes Simplex Virus Subuait Vaccine)의 제조방법
US3674864A (en) Process for stabilizing preparations of interfering viruses
Kurrle et al. Influenza virus‐specific T cell‐mediated cytotoxicity: integration of the virus antigen into the target cell membrane is essential for target cell formation
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES8203225A1 (es) Procedimiento para aislar antigenos glicoproteicos de un vi-rus
GB1292803A (en) Improvements relating to the production of antigens
Wilcox et al. Soluble Antigens of Vaccinia-infected Mammalian Cells II. Time Course of Synthesis of Soluble Antigens and Virus Structural Proteins
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
GB1488800A (en) Influenza vaccines
IE40180L (en) Influenza virus vaccines.
Russell et al. Mumps Viral Cytolysin: I. Action on Human Epithelial Cells in Tissue Culture
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
AU5573196A (en) A pluripotent vaccine against enveloped viruses
GB660109A (en) Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine
US3132073A (en) Measles vaccine
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
Greer et al. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
ES350690A1 (es) Un metodo para la concentracion y purificacion de los virusdel grupo de la influenza.
Danes et al. Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. II. The inactivation by formaldehyde of the tickborne encephalitis virus in liquids prepared from tissue cultures. Immunogenic properties

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500130-5

Effective date: 19940810

Format of ref document f/p: F